stella
beta
Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome — Stella
Recruiting
Back to Crigler-Najjar Syndrome trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
France
Hopital Antoine BECLERE, Clamart
View full record on ClinicalTrials.gov